About
Acceptance rate:
15%
Time to first decision:
6 days*
Time to first decision with review:
40 days*
Impact Factor (JCR):
5.945
Impact Factor rank (JCR):
28/175
Citescore:
10.1
Aims and scope
Journal of Medical Genetics is a leading international peer-reviewed journal covering original research in human genetics, including reviews of and opinion on the latest developments. Articles cover the molecular basis of human disease including germline cancer genetics, clinical manifestations of genetic disorders, applications of molecular genetics to medical practice and the systematic evaluation of such applications worldwide.
For information about the Journal of Medical Genetics Editor-in-Chief Huw Dorkins and his editorial team, please refer to the Editorial Board page.
Transitioning to a greener future
From January 2023, Journal of Medical Genetics will publish solely online. This change brings significant climate and environmental benefits. Transitioning to online-only means we can completely eliminate the substantial use of energy, water and chemicals that is involved in the complex production and distribution process of a print journal.
Most of our readers already use our website jmg.bmj.com for most of their needs, the website after all offers readers a far richer experience with more content overall. We hope that this change does not cause too much inconvenience for our readers as we move towards a greener future for Journal of Medical Genetics.
Plan S compliance
Journal of Medical Genetics is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Journal information
Ownership
Journal of Medical Genetics is owned by BMJ. The journal has been adopted as the official journal of the Canadian College of Medical Geneticists
Publication Model
Subscription; with hybrid open access option
Frequency
Monthly
Launch date
1964
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
0022-2593
Online ISSN
1468-6244
Journal Statistics (2021)
Acceptance rate: 15%
Speed
Time to first decision without review (median): 6 days
Time to first decision with review (median): 40 days
Time from acceptance to publication (median): 20 days
Impact
Impact Factor category: Genetics & Heredity
Impact Factor (JCR): 5.945
Impact Factor rank: 28/175
5 year Impact Factor: 6.451
Journal Citation Indicator (JCI): 1.40
Eigenfactor: 0.01046
Citescore: 10.1
Citescore rank: 9/86
Scimago Journal rank (SJR): 1.767
Reach
2021 total content views: 541,578
2021 total Altmetric mentions: 1,172
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the contact us page.
For authors
Please refer to the Instructions for Authors.
Subscriptions
To advertise
Rights and permissions
Affiliations
The Journal of Medical Genetics is an official journal of the Canadian College of Medical Geneticists.
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.